R. Morton

发表

Anti-tumor activity of CCI-779 in relapsed mantle cell lymphoma

P. Kurtin, S. Geyer, S. Ansell, 2009 .

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.

M. Somerfield, R. Schilsky, S. Hamilton, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gliomas and Farm Pesticide Exposure in Women: The Upper Midwest Health Study

W. Sanderson, D. Reding, M. Butler, 2005, Environmental health perspectives.

The Upper Midwest Health Study: industry and occupation of glioma cases and controls.

Kathleen M Waters, D. Reding, M. Butler, 2012, American journal of industrial medicine.

Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.

P. Novotny, J. Sloan, C. Loprinzi, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Pathway Through the Bundle Jungle.

R. Conti, R. Morton, B. Polite, 2016, Journal of oncology practice.

Why do oncologists prescribe--or not prescribe--conventional chemotherapy to geriatric patients with metastatic non-small cell lung cancer?

S. Hillman, K. Rowland, S. Dakhil, 2006, The journal of supportive oncology.

Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

D. Sargent, S. Thibodeau, H. McLeod, 2010, Journal of Clinical Oncology.

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.

D. Sargent, C. Fuchs, R. Goldberg, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program.

D. Sargent, R. Goldberg, J. Krook, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ASCO Provisional Clinical Opinion: KRAS, Cetuximab, and Panitumumab-Clinical Implications in Colorectal Cancer.

E. Hammond, R. Morton, 2009, Journal of oncology practice.

NCCTG Study N9741: leveraging learning from an NCI Cooperative Group phase III trial.

J. Buckner, D. Sargent, H. McLeod, 2009, The oncologist.

Phase II trials of 5‐fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma

J. Kugler, R. Morton, J. Rubin, 1996, Cancer.

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

Daniel J Sargent, D. Sargent, C. Fuchs, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial.

P. Novotny, J. Sloan, C. Loprinzi, 2007, Mayo Clinic proceedings.

Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial

P. Novotny, J. Sloan, C. Loprinzi, 2006 .

Reproductive factors and risk of glioma in women.

D. Reding, M. Butler, J. Mandel, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.

B. Scheithauer, J. O'fallon, T. Cascino, 2001, Cancer.

Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.

E. Perez, K. Rowland, W. Lingle, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

N9741: FOLFOX (oxaliplatin(Oxal)/ 5-fluorouracil (5-FU)/ leucovorin (LV) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study.

D. Sargent, C. Fuchs, R. Goldberg, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A comparison of simple single-item measures and the common toxicity criteria in detecting the onset of oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer

D. Sargent, J. Sloan, H. McLeod, 2005 .

A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.

K. Rowland, S. Dakhil, P. Flynn, 2007, Urology.

Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group

N. Foster, J. Kugler, S. Alberts, 2005, Supportive Care in Cancer.

The Upper Midwest Health Study: gliomas and occupational exposure to chlorinated solvents

P. Stewart, D. Reding, M. Butler, 2012, Occupational and Environmental Medicine.

PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study.

P. Schaefer, N. Foster, J. Kugler, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Anti-tumor activity of mTOR inhibitor temsirolimus for relapsed mantle cell lymphoma: A phase II trial in the North Central Cancer Treatment Group.

S. Ansell, S. Dakhil, S. Kaufmann, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of a Supermarket Intervention to Increase Consumption of Fruits and Vegetables

A. Kristal, R. Morton, L. Goldenhar, 1997, American journal of health promotion : AJHP.

A Randomized Phase II and Pharmacokinetic Study of Dacarbazine in Patients with Recurrent Glioma

B. Scheithauer, J. Buckner, S. Vincent Rajkumar, 2000, Journal of Neuro-Oncology.

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM

J. Uhm, R. Arusell, J. Buckner, 2010, Journal of Neuro-Oncology.

Long‐term results of the treatment of patients with mantle cell lymphoma with cladribine (2‐CDA) alone (95‐80‐53) or 2‐CDA and rituximab (N0189) in the North Central Cancer Treatment Group

R. Fonseca, S. Ansell, T. Witzig, 2008, Cancer.

Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial.

Randy L. Moore, J. O'fallon, R. Morton, 1996, International journal of radiation oncology, biology, physics.

N9741: FOLFOX (oxaliplatin(Oxal)/ 5-fluorouracil (5-FU)/ leucovorin (LV) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study.

D. Sargent, C. Fuchs, R. Goldberg, 2004, Journal of Clinical Oncology.

A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia

D. Sargent, R. Goldberg, K. Rowland, 2002, International journal of gastrointestinal cancer.

Phase II trial of edatrexate in small cell lung cancer

J. Jett, R. Morton, John Q. Su, 1994, Cancer.

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non‐small cell lung cancer. A trial of the north central cancer treatment group

J. Jett, J. Krook, R. Morton, 1993, Cancer.

A Phase II Study of Topical Ceramides for Cutaneous Breast Cancer

J. Sloan, C. Loprinzi, S. Alberts, 2003, Breast Cancer Research and Treatment.

Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.

B. Scheithauer, R. Dinapoli, J. Buckner, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Alternating Chemotherapy With or Without VP‐16 in Extensive‐Stage Small‐Cell Lung Cancer

J. O'fallon, J. Jett, J. Laurie, 1989, American journal of clinical oncology.

Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor

B. Scheithauer, J. O'fallon, T. Cascino, 1996, Journal of Neuro-Oncology.

Postsurgical changes of the breast that mimic inflammatory breast carcinoma.

T. Pisansky, C. Loprinzi, R. Morton, 1996, Mayo Clinic proceedings.

Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer.

J. Jett, J. Sloan, R. Morton, 1999, American journal of clinical oncology.

Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trials.

J. O'fallon, E. Messing, P. Novotny, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma.

J. Kugler, R. Morton, D. Ahmann, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy for hormonally refractory advanced prostate carcinoma. A Comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5‐fluorouracil

T. Therneau, J. Laurie, J. Krook, 1992, Cancer.

Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma.

B. Scheithauer, J. O'fallon, R. Dinapoli, 1999, American journal of clinical oncology.

Phase II Study of Enzalutamide for Patients With Androgen Receptor–Positive Salivary Gland Cancers (Alliance A091404)

N. Foster, G. Schwartz, N. Katabi, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.

Caterina Giannini, Jan C Buckner, Paul D Brown, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma.

R. Fonseca, S. Dakhil, S. Kaufmann, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.

D. Schaid, R. Goldberg, C. Loprinzi, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase III study of radiation therapy plus carmustine with or without recombinant interferon‐α in the treatment of patients with newly diagnosed high‐grade glioma

B. Scheithauer, J. O'fallon, T. Cascino, 2001 .

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance])

J. Sloan, C. Loprinzi, T. Sio, 2016, Supportive Care in Cancer.

Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.

D. Sargent, J. Krook, J. Kugler, 2006, Clinical colorectal cancer.

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.

B. Scheithauer, J. Buckner, M. Hidalgo, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.

Henry C. Pitot, Daniel J. Sargent, Stephen K. Williamson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma

V. Suman, S. Markovic, R. Morton, 2009, Cancer.

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer: A randomized, phase III trial

T. Therneau, J. Earle, J. Jett, 1991 .

Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma

B. Scheithauer, J. O'fallon, R. Dinapoli, 1997, Journal of Neuro-Oncology.

Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas.

J. O'fallon, R. Dinapoli, J. Buckner, 2000, Journal of neurosurgery.

The Upper Midwest Health Study: a case-control study of primary intracranial gliomas in farm and rural residents.

D. Reding, M. Butler, J. Mandel, 2006, Journal of agricultural safety and health.

Myelodysplastic syndrome treatment with danazol and cis‐retinoic acid

R. Morton, J. Mailliard, R. Levitt, 1995, American journal of hematology.

Phase II trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma

V. Suman, R. Morton, T. Amatruda, 2007 .

CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.

B. Scheithauer, J. O'fallon, B. O'neill, 2011, International journal of radiation oncology, biology, physics.

Low‐dose, single‐agent temsirolimus for relapsed mantle cell lymphoma

D. Moore, S. Ansell, K. Rowland, 2008, Cancer.

Phase II study of amonafide in patients with recurrent glioma

Jan C. Buckner, B. Scheithauer, J. O'fallon, 2005, Journal of Neuro-Oncology.

A Dose-Escalation Study of Aerosolized Sargramostim in the Treatment of Metastatic Melanoma: An NCCTG Study

K. Rowland, M. Pittelkow, V. Suman, 2008, American journal of clinical oncology.

Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.

D. Sargent, C. Fuchs, R. Goldberg, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors

B. Scheithauer, J. Buckner, J. Krook, 1999, Cancer.

Payment for oncolytics in the United States: a history of buy and bill and proposals for reform.

R. Conti, R. Morton, B. Polite, 2014, Journal of oncology practice.

Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.

D. Schaid, C. Loprinzi, R. Morton, 1994, Oncology.

Gliomas and Farm Pesticide Exposure in Men: The Upper Midwest Health Study

W. Sanderson, D. Reding, M. Butler, 2004, Archives of environmental health.

CPT-11 for bile-duct and gallbladder carcinoma

R. Goldberg, L. Burgart, S. Alberts, 2002, International journal of gastrointestinal cancer.

The upper midwest health study: a case–control study of pesticide applicators and risk of glioma

P. Stewart, D. Reding, M. Butler, 2012, Environmental Health.

Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma.

R. Morton, E. Creagan, M. Chang, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Associations between Plasma Insulin-Like Growth Factor Proteins and C-Peptide and Quality of Life in Patients with Metastatic Colorectal Cancer

J. Meyerhardt, D. Sargent, J. Sloan, 2005, Cancer Epidemiology Biomarkers & Prevention.

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive‐stage small cell lung carcinoma

J. Jett, S. Hillman, R. Marks, 2003, Cancer.

Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.

R. Hurt, P. Novotny, J. Sloan, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nicotine P atch T herapy B ased o n S moking R ate F ollowed b y Bupropion f or P revention o f R elapse t o S moking

R. Hurt, P. Novotny, J. Sloan, 2003 .

The prevalence of weight concerns in a smoking abstinence clinical trial.

M. Clark, C. Patten, R. Hurt, 2006, Addictive behaviors.

Exposure to farm crops, livestock, and farm tasks and risk of glioma: the Upper Midwest Health Study.

D. Reding, M. Butler, J. Mandel, 2009, American journal of epidemiology.

A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study.

J. Jett, S. Mandrekar, M. Aubry, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

N9741: Survival update and prognostic factor analysis of oxaliplatin (Ox) and irinotecan (Iri) combinations for metastatic colorectal cancer (MCRC)

D. Sargent, C. Fuchs, R. Goldberg, 2007 .

Mortality associated with daily bolus 5‐fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin

D. Sargent, R. Goldberg, R. Morton, 2004, Cancer.

Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX)

D. Sargent, R. Goldberg, A. Grothey, 2007, Cancer.

Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.

D. Sargent, C. Fuchs, R. Goldberg, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic polymorphisms, toxicity, and response rate in African Americans (AA) with metastatic colorectal cancer (MCRC) compared to Caucasians (C) when treated with IFL, FOLFOX or IROX in Intergroup N9741.

D. Sargent, H. McLeod, C. Fuchs, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preliminary evidence of relationship between genetic markers and oncology patient quality of life (QOL).

D. Sargent, J. Sloan, H. McLeod, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment Group.

N. Foster, S. Nair, R. Morton, 2004, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

A randomized trial of interferon‐alpha in cervical dysplasia

J. A. Jefferies, V. Suman, R. Morton, 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Anti-Tumor Activity of Single-Agent CCI-779 for Relapsed Mantle Cell Lymphoma: A Phase II Trial in the North Central Cancer Treatment Group.

R. Fonseca, K. Rowland, S. Dakhil, 2004 .

Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer

P. Novotny, J. Sloan, C. Fuchs, 2023, Cancer control : journal of the Moffitt Cancer Center.

Effective surgical adjuvant therapy for high-risk rectal carcinoma.

W. Meyers, S. Cha, H. Wieand, 1991, The New England journal of medicine.

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

T. Fleming, H. Wieand, J. Laurie, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of rituximab and cladribine (2-CDA) in newly diagnosed mantle cell lymphoma (MCL) (N0189).

S. Dakhil, R. Morton, W. White, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

D. Sargent, S. Thibodeau, H. McLeod, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCTG Study N9741: leveraging learning from an NCI Cooperative Group phase III trial.

J. Buckner, D. Sargent, H. McLeod, 2009, The oncologist.

Associations between Plasma Insulin-Like Growth Factor Proteins and C-Peptide and Quality of Life in Patients with Metastatic Colorectal Cancer

J. Meyerhardt, D. Sargent, J. Sloan, 2005, Cancer Epidemiology Biomarkers & Prevention.

Utilization of cancer early detection services among farm and rural nonfarm adults in Iowa.

M. Schootman, R. Morton, J. Muldoon, 1996, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

Efficacy and toxicity of cetuximab (C225) plus mFOLOFX6 in patients (pts) with nonoptimally resectable, colorectal metastases (MCRC) confined to the liver

J. Donohue, J. Kugler, S. Alberts, 2008 .

Phase II evaluation of menogaril in patients with advanced cervical carcinoma

R. Goldberg, G. Malkasian, J. Laurie, 1991, Investigational New Drugs.